Amlodipine May Reduce Adverse CV Events in Normotensive...

"Amlodipine reduces adverse cardiovascular (CV) events in patients with coronary artery disease (CAD) and normal blood pressure (BP), according to the results of a randomized trial published in the Nov. 10 issue of JAMA. Intravascular ultrasound (IVUS) in these patients also suggests a slowing of atherosclerotic progression."